Published in JAMA on April 01, 1988
HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health (1993) 3.05
Education for AIDS prevention: not our only voluntary weapon. Am J Public Health (1989) 1.18
AIDS-related behavioral research and nursing. J Natl Med Assoc (1991) 0.75
Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet (1999) 8.91
HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. JAMA (1989) 6.68
HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet (1996) 5.43
Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA (1995) 4.88
Structural interventions: concepts, challenges and opportunities for research. J Urban Health (2006) 4.70
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS (1987) 3.78
Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann Intern Med (1985) 3.63
Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992. JAMA (1994) 3.41
Sociometric risk networks and risk for HIV infection. Am J Public Health (1997) 3.29
HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS (1987) 3.24
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. Am J Public Health (1995) 3.24
International epidemiology of HIV and AIDS among injecting drug users. AIDS (1992) 3.19
Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav (1988) 3.14
The relevance of drug injectors' social and risk networks for understanding and preventing HIV infection. Soc Sci Med (1994) 3.05
A randomized trial of an interim methadone maintenance clinic. Am J Public Health (1991) 2.99
Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am J Epidemiol (2000) 2.95
AIDS health education for intravenous drug users. Health Educ Q (1986) 2.92
HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcomes, and prevention. Rev Infect Dis (1988) 2.91
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic. Am J Public Health (2000) 2.74
AIDS and self-organization among intravenous drug users. Int J Addict (1987) 2.73
Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. The National AIDS Research Consortium. Am J Epidemiol (1995) 2.66
The AIDS epidemic among blacks and Hispanics. Milbank Q (1987) 2.54
High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 2.38
Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am J Public Health (1998) 2.28
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health (2001) 2.21
A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York City. Science (1988) 2.20
Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction (2001) 2.17
Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997. Am J Public Health (2000) 2.09
Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health (2001) 2.02
Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution. Sex Transm Infect (2006) 2.00
HIV and HCV infection among injecting drug users. Mt Sinai J Med (2000) 1.96
Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med (1996) 1.93
Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done. Public Health Rep (1998) 1.92
Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.87
Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS (2001) 1.80
Harm reduction--a framework for incorporating science into drug policy. Am J Public Health (1995) 1.75
Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. Am J Epidemiol (2001) 1.73
Syringe-mediated drug-sharing (backloading): a new risk factor for HIV among injecting drug users. AIDS (1993) 1.72
Regulating controversial programs for unpopular people: methadone maintenance and syringe exchange programs. Am J Public Health (1995) 1.72
The epidemic of acquired immunodeficiency syndrome (AIDS) and suggestions for its control in drug abusers. J Subst Abuse Treat (1984) 1.70
Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care (1999) 1.70
Measuring the effects of an international health professions faculty development fellowship: the FAIMER Institute. Med Teach (2010) 1.68
AIDS and the transition to illicit drug injection--results of a randomized trial prevention program. Br J Addict (1992) 1.68
Recommendations for control and prevention of human immunodeficiency virus (HIV) infection in intravenous drug users. Ann Intern Med (1989) 1.65
HIV among drug injectors: the epidemic and the response. AIDS Care (1991) 1.64
Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18- to 24-year-old youth in a high-risk neighborhood. Sex Transm Dis (2001) 1.62
High compliance with a hepatitis B virus vaccination program among intravenous drug users. J Infect Dis (1991) 1.60
Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS (1987) 1.60
Risk factors and HIV seropositivity among injecting drug users in Bangkok. AIDS (1991) 1.60
Harm reduction: a public health response to the AIDS epidemic among injecting drug users. Annu Rev Public Health (1993) 1.57
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use. Am J Public Health (1996) 1.51
AIDS and i.v. drug use. Science (1989) 1.51
Self-reports of HIV risk behavior by injecting drug users: are they reliable? Addiction (1995) 1.49
Drug scene roles and HIV risk. Addiction (1998) 1.45
Shooting galleries and AIDS: infection probabilities and 'tough' policies. Am J Public Health (1990) 1.43
Outreach to injecting drug users and female sexual partners of drug users on the lower east side of New York City. Br J Addict (1992) 1.42
AIDS and the new drug injector. Nature (1989) 1.41
Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Res Monogr (1995) 1.41
Effects of outreach intervention on risk reduction among intravenous drug users. AIDS Educ Prev (1990) 1.37
Keeping it together: stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents. AIDS Care (2005) 1.37
The study of transitions in the route of drug use: the route from one route to another. Br J Addict (1992) 1.36
Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996. J Acquir Immune Defic Syndr (1999) 1.36
Intravenous drug use and the heterosexual transmission of the human immunodeficiency virus. Current trends in New York City. N Y State J Med (1987) 1.32
HIV risk behaviours of current sex workers attending syringe exchange: the experiences of women in five US cities. AIDS Care (1999) 1.32
Implications of directly observed therapy in tuberculosis control measures among IDUs. Public Health Rep (1994) 1.30
Tuberculosis in drug users. Clin Infect Dis (1995) 1.30
Working with heroin sniffers: clinical issues in preventing drug injection. J Subst Abuse Treat (1990) 1.28
Methadone maintenance patients in general medical practice. A preliminary report. JAMA (1988) 1.28
An interview study of participants in the Tacoma, Washington, syringe exchange. Addiction (1993) 1.27
Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. J Med Virol (1989) 1.27
HIV infection among persons who inject illicit drugs: problems and prospects. J Acquir Immune Defic Syndr (1988) 1.25
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease. Proc Natl Acad Sci U S A (1987) 1.24
Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users. J Subst Abuse (2001) 1.22
AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok. Am J Public Health (1994) 1.21
Social intervention against AIDS among injecting drug users. Br J Addict (1992) 1.21
Hepatitis C virus-specific T-cell immune responses in seronegative injection drug users. J Viral Hepat (2008) 1.21